Page 8 - Anticompetitive Practices News Today : Breaking News, Live Updates & Top Stories | Vimarsana

>>dave: and now the news. 70 million, that is amount of money general electric agreed to pay other allegations that the finance division engaged in anticompetitive practices. next, 1.4 million minimum wage workers receive a boost between 28 cents and 37 cents an hour. and five, the number of outfit changes kate middleton will make for the royal christmas. >>juliet: a roller coaster for congress over the payroll tax cut but can lawmakers learn anything from the bipartisan showdown? >> this congress has had a very good learning experience. especially those who are new to

And holding ten for the big guy. that would have blown up the race and taped it in the president's favor. there is a study on that. they also suppressed factual information about the lab leak, and they said anybody telling the truth about that was lying. and that was also very wrong. they are engaged in a ton of anticompetitive practices, antibusiness practices, and need to be held accountable. that's what the president is doing. they just ripped this guy's vocal cords out of his throat is a very critical time in our nations history. do i think the lawsuit is going anywhere? i've got to be hon...

Thank you. >> thank you. >> tucker: european legislators bill millions engaging in anticompetitive practices. american regulators, meanwhile, are nowhere to be found. why is that exactly? luther lowe is the senior vice president of public policy for yep and he joins us now. luther, thanks for coming. >> thanks for having me on. >> tucker: always particularly happy to talk to you since you write for a big tech company. really simple question google has a monopoly. nobody debates that monopolies are supposed to be banned by u.s. law. a whole congress with 535 people in it designed to protect us ...

Vibrant generic drug industry and generic drug market. we need to foster and nurture a new, competitive bio similar generic drug market, those are the generics for those really complex expensive biologic medicines. need to foster and nurture that. we also have to get after pharma companies who engage in anticompetitive practices and try to block the entry of generics or bio similar products to market. like for instance, blocking access to their products so they can't do the studies they need to do in order to get approval of an affordable generic or bio similar market. so we will go after all ...